Dr. Lieping Chen is an United Technologies Corporation Professor in Cancer Research, Professor of Immunobiology, Medicine (Medical Oncology) and Dermatology in Yale School of Medicine. He earned his medical degree from Fujian Medical College in Fuzhou, China. After clinical and research trainings in immunology and oncology in Fujian Union Hospital and Beijing Union Medical College, he got a PhD in Pathology from Drexel University in Philadelphia, Pennsylvania and did a postdoctoral fellowship in the University of Washington in Seattle. He worked as a research scientist in cancer and immunology discovery group in Bristol-Myers Squibb/Oncogen in Seattle from 1989-1997 before he moved to Mayo Clinic in Rochester, Minnesota as an Immunology Professor and Consultant from 1997-2004. He was Professor of Oncology and Dermatology at Johns Hopkins University School of Medicine in Baltimore, Maryland for 7 years and joined Yale since 2010.
Dr. Chen has published more than 350 research articles, reviews and book chapters and edited two books. His work in discovery of the PD-1/PD-L1 pathway for cancer immunotherapy was cited as the #1 breakthrough of the years by Science magazine 2013. He is a member of U.S. National Academy of Sciences and a Fellow of American Association for Cancer Research.